IP Library Granted Patent US 11,013,712
Granted Patent B2
US 11,013,712 · App. 13/612,328 · Granted May 25, 2021

Methods of treating insomnia using a combination therapy of low-dose doxepin and zolpidem

Inventors: Philip Jochelson (San Diego, CA); Robert Mansbach (San Diego, CA); Michael Skinner (San Diego, CA); Neil B. Kavey (Chappaqua, NY)
Assignee: Currax Pharmaceuticals LLC
A61K31/335A61K31/343A61K31/4162A61K31/437A61K31/4535A61K31/4985A61K31/505A61P25/00A61P25/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,013,712
App. No.
13/612,328
Granted
May 25, 2021
Kind
B2
Abstract

A composition comprising doxepin, or a pharmaceutically acceptable salt, or prodrug thereof, and a compound that enhances sleep onset, sleep maintenance or reduces early morning awakenings. These compositions are useful for treating multiple manifestations of insomnia.

Claims (13)

1. A method of treating insomnia in a human patient in need thereof, the method comprising:

administering to the patient a composition consisting essentially of:

about 0.5 mg to about 7 mg of doxepin hydrochloride;

about 0.1 mg to about 4.5 mg of zolpidem tartrate; and

one or more pharmaceutical excipients.

2. The method of claim 1 , wherein the composition comprises between about 0.5 mg and about 6 mg of doxepin hydrochloride.

3. The method of claim 2 , wherein the composition comprises between about 1 mg and about 6 mg of doxepin hydrochloride.

4. The method of claim 3 , wherein the composition comprises about 1 mg of doxepin hydrochloride.

5. The method of claim 3 , wherein the composition comprises about 3 mg of doxepin hydrochloride.

6. The method of claim 3 , wherein the composition comprises about 6 mg of doxepin hydrochloride.

7. The method of claim 1 , wherein the composition is administered by an oral, buccal, sublingual, transdermal, rectal, topical, transmucosal, intestinal or parenteral route of administration.

8. The method of claim 1 , wherein the one or more excipient is selected from the group consisting of: diluents, disintegrants, binding agents, adhesives, wetting agents, polymers, lubricants, glidants, substances added to mask or counteract a disagreeable taste or odor, flavors, dyes, fragrances, and substances added to improve appearance of the composition.

9. The method of claim 1 , wherein the one or more excipient is selected from the group consisting of: lactose, sucrose, mannitol, sorbitol, other sugars, starch powder, maize starch or derivatives thereof, wheat starch, rice starch, potato starch, gelatin, gum tragacanth, methyl cellulose, hydroxypropylmethyl cellulose, sodium carboxymethylcellulose, cellulose esters of alkanoic acids, cellulose alkyl esters, talc, stearic acid, magnesium stearate, magnesium oxide, sodium and calcium salts of phosphoric and sulfuric acids, gelatin, acacia gum, sodium alginate, polyvinyl-pyrrolidone, polyvinyl alcohol, saline, dextrose, lecithin, albumin, sodium glutamate, and cysteine hydrochloride.

Assignments (7)
SECURITY INTEREST Recorded Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2019
From: PERNIX SLEEP, INC.
To: CURRAX PHARMACEUTICALS LLC
Reel/Frame 049329/0730 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2015
From: PERNIX THERAPEUTICS HOLDINGS, INC.
To: PERNIX SLEEP, INC.
Reel/Frame 036387/0667 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS REEL/FRAME 030441/0229 Recorded Feb 24, 2014
From: MIDCAP FUNDING IV, LLC (SUCCESSOR IN INTEREST TO MIDCAP FINANCIAL, LLC)
To: PERNIX SLEEP, INC.
Reel/Frame 032330/0023 →
MERGER Recorded Feb 3, 2014
From: SOMAXON PHARMACEUTICALS, INC.
To: PERNIX THERAPEUTICS HOLDINGS, INC.
Reel/Frame 032118/0272 →
PATENT TRANSFER AND ASSIGNMENT Recorded Sep 13, 2013
From: MIDCAP FUNDING V, LLC
To: MIDCAP FINANCIAL, LLC
Reel/Frame 031266/0437 →
PATENT TRANSFER AND ASSIGNMENT Recorded Sep 13, 2013
From: MIDCAP FINANCIAL, LLC
To: MIDCAP FUNDING IV, LLC
Reel/Frame 031266/0572 →